Aufero Medical

TruContact is a robotic tool that enhances catheter stability for ablation therapy to better treat atrial fibrillation and other heart rhythm disorders.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location London, ON, Canada
  • Currency USD
  • Founded July 2017
  • Employees 2
  • Incorporation Type C-corp
  • Website auferomedical.com

Company Summary

Aufero enhances cardiac ablation with TruContact, an accessory to stabilize catheters during AFib treatment. Based in Canada, it's at MVP/Seed stage. Targeting EP labs, we'll employ a razor-razorblade model with capital equipment sales and consumables. Aims for global market entry by 2027, with strategic partnerships and patents. Seeking $3-4M to launch new partnership with Abbott (global EP leader), product dev, and early clinical feasibility.

Team

  • Maria Drangova

    Scientist, Robarts Research Institute

    Dr. Drangova is an expert in medical imaging and devices with a focus on cardiovascular applications. She holds four patents and is the co-founder of an MRI QA device company. Dr. Drangova is well-connected and has enabled Aufero with incredibly strong institutional support. She has lead the team in acquiring research funds to support the development and initial commercialization efforts of the technology.

  • Allan Skanes

    Director, London Heart Rhythm Program, London Health Sciences Centre

    Dr. Skanes is an internationally respected key-opinion leader for catheter-based treatment of atrial fibrillation and other heart arrhythmias. He currently sits on the advisory board for several multi-national companies and policy-making bodies.

  • Daniel Gelman
    CEO

    Dr. Gelman is a Biomedical Engineer and the principal investor of Aufero's technology. He has an extensive background in medical device innovation, specifically in catheter-based cardiovascular interventions. Daniel has worked intimately with national and multi-national medical device companies and has acted as a consulted for pre-clinical testing of novel catheter-based devices.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free